Kaken Pharmaceutical Co., Ltd.

OTCPK:KKPC.F Stock Report

Market Cap: US$982.6m

Kaken Pharmaceutical Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Hiroyuki Horiuchi

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure4.3yrs
CEO ownership0.02%
Management average tenureno data
Board average tenure4.3yrs

Recent management updates

Recent updates

CEO

Hiroyuki Horiuchi

4.3yrs

Tenure

Mr. Hiroyuki Horiuchi serves as Director of Kaken Pharmaceutical Co. Ltd. since June 2016 and its President since June 2020. He was Chief Officer of Marketing & Sales of Kaken Pharmaceutical Co. Ltd.since...

Board Members

NamePositionTenureCompensationOwnership
Hiroyuki Horiuchi
President & Representative Director8.3yrsno data0.020%
¥ 199.8k
Masashi Suzudo
GM of Corporate Planning & Coordination Department and Director3.3yrsno data0.0084%
¥ 83.0k
Hirotoshi Endo
Outside Audit & Supervisory Board Member5.3yrsno datano data
Yoshio Tanabe
Director8.3yrsno datano data
Shoichiro Takagi
Independent Outside Director4.3yrsno data0.0013%
¥ 13.0k
Minoru Ohta
Director4.3yrsno data0.0040%
¥ 38.9k
Yasutomo Inoue
Independent Outside Director3.3yrsno data0.00026%
¥ 2.6k
Naomi Doi
Standing Audit & Supervisory Board Member6.3yrsno datano data
Kiyoko Kamibeppu
Independent Outside Director5.3yrsno data0.0011%
¥ 10.4k
Masahiro Matsuura
Director4.3yrsno data0.014%
¥ 140.1k
Hiroaki Matsumoto
Outside Audit & Supervisory Board Member3.3yrsno data0.0011%
¥ 10.4k
Kazumori Ishiguro
Standing Audit & Supervisory Board Member2.3yrsno data0.0050%
¥ 49.3k

4.3yrs

Average Tenure

63yo

Average Age

Experienced Board: KKPC.F's board of directors are considered experienced (4.3 years average tenure).